First-in-Human Phase I Clinical Trial of the Adenosine A1R/A3R Agonist AST-004 in Healthy Subjects.
| Publicado en: | Stroke (00392499) Vol. 55; no. 12; pp. 2795 - 2804 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
Dec2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=181039982&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 181039982 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00392499 1FT jtl: Stroke (00392499) issn: 00392499 maglogo: N pubinfo: dt: Dec2024 vid: 55 iid: 12 pid: 433 pub: Lippincott Williams & Wilkins place: Baltimore, Maryland artinfo: ui: 181039982 10.1161/STROKEAHA.124.047207 181039982 ppf: 2795 ppct: 9 formats: tig: atl: First-in-Human Phase I Clinical Trial of the Adenosine A1R/A3R Agonist AST-004 in Healthy Subjects. aug: au: Manna, Lisa M. Hernandez, Juan Hunt, Dawn E. Lakner, Géza Matson, Mark A. Poe, Russell B. Korinek, William S. Lancey, Robert A. Liston, Theodore E. affil: Astrocyte Pharmaceuticals, Inc, Groton, CT (L.M.M., J.H., D.E.H., M.A.M., T.E.L., R.B.P., W.S.K., R.A.L.). sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|